Post-treatment Visual Acuity Prediction Using Deep Learning in Age-related Macular Degeneration

被引:0
|
作者
Kim, Najung [1 ]
Kim, Hyung Chan [1 ]
Chung, Hyewon [1 ]
Lee, Hyungwoo [1 ,2 ]
机构
[1] Konkuk Univ, Med Ctr, Sch Med, Dept Ophthalmol, Seoul, South Korea
[2] Konkuk Univ, Med Ctr, Dept Ophthalmol, 120-1 Neungdong Ro, Seoul 05030, South Korea
来源
JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY | 2023年 / 64卷 / 07期
基金
新加坡国家研究基金会;
关键词
Age-related macular degeneration; Deep learning; Prediction; Visual acuity; RISK-FACTORS; RANIBIZUMAB; PREVALENCE; OUTCOMES; THERAPY;
D O I
10.3341/jkos.2023.64.7.582
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To develop a deep learning model to predict visual acuity (VA) outcomes after 12 months of anti-vascular endothelial growth factor (anti-VEGF) treatment.Methods: A total of 330 treatment-naive eyes of neovascular age-related macular degeneration patients, who underwent anti-VEGF therapy between 2007 and 2020 at Konkuk University medical center, were included. The network was trained using VA at baseline, VA after three loading doses of anti-VEGF, and treatment regimen data. It was also trained using 12,300 augmented optical coherence tomography (OCT) B-scan images at baseline and after three loading doses of anti-VEGF. We generated five deep learning models using sequentially input data (VA and OCT B-scan images at baseline and after three loading doses, and treatment regimen). Prediction of VA at 12 months was performed using deep learning algorithms, such as convolutional neural network and multilayer perceptron. The outcomes were dichotomized based on whether the decremental change in VA during the 12 months of treatment was more or less than logarithm of the minimum angle of resolution 0.3. Predictive efficiency was assessed by comparing the performance of deep learning models.Results: The best performing model was trained using input data, including VA at baseline and after three loading doses, treatment regimen, and OCT B-scan images at baseline and after three loading doses. The decremental outcome in VA after 12 months of anti-VEGF treatment was predicted as an area under the curve (AUC) of 0.79. The addition of OCT images at baseline and after three loading doses as input data improved the AUC, sensitivity, and negative predictive value (AUC 0.74-0.79, 0.58-0.86, and 0.90-0.95, respectively). Conclusions: Our deep learning model showed relatively good performance in classifying good or poor post-treatment VA based on combined clinical information including numerical and image data. J Korean Ophthalmol Soc 2023;64(7):582-590
引用
收藏
页码:582 / 590
页数:9
相关论文
共 50 条
  • [21] Modeling Visual Acuity in Geographic Atrophy Secondary to Age-Related Macular Degeneration
    Schmitz-Valckenberg, Steffen
    Nadal, Jennifer
    Fimmers, Rolf
    Lindner, Moritz
    Holz, Frank G.
    Schmid, Matthias
    Fleckenstein, Monika
    OPHTHALMOLOGICA, 2016, 235 (04) : 215 - 224
  • [22] Visual acuity after cataract surgery in patients with age-related macular degeneration
    Baatz, H.
    Darawsha, R.
    Scharioth, G.
    De Ortueta, D.
    Ackermann, H.
    OPHTHALMOLOGE, 2008, 105 (10): : 927 - 930
  • [23] Visual acuity and its decrease in classic neovascular age-related macular degeneration
    Behrendt, CE
    OPHTHALMIC EPIDEMIOLOGY, 2004, 11 (05) : 359 - 367
  • [24] Intravitreal treatment in patients with exudative age-related macular degeneration and visual acuity ≤ 0.05
    Raphael Koch
    Matthias Schmidt
    Sabine Gebauer
    Holger Busse
    Constantin E. Uhlig
    BMC Ophthalmology, 15
  • [25] Intravitreal treatment in patients with exudative age-related macular degeneration and visual acuity ≤ 0.05
    Koch, Raphael
    Schmidt, Matthias
    Gebauer, Sabine
    Busse, Holger
    Uhlig, Constantin E.
    BMC OPHTHALMOLOGY, 2015, 15
  • [26] Visual acuity loss associated with excessive "dry macula" in exudative age-related macular degeneration
    Takahashi, Hidenori
    Inoue, Yuji
    Tan, Xue
    Inoda, Satoru
    Sakamoto, Shinichi
    Arai, Yusuke
    Yanagi, Yasuo
    Fujino, Yujiro
    Kawashima, Hidetoshi
    CLINICAL OPHTHALMOLOGY, 2018, 12 : 369 - 375
  • [27] Relationship between macular pigment and visual acuity in eyes with early age-related macular degeneration
    Puell, Maria C.
    Palomo-Alvarez, Catalina
    Barrio, Ana R.
    Gomez-Sanz, Fernando J.
    Jesus Perez-Carrasco, Maria
    ACTA OPHTHALMOLOGICA, 2013, 91 (04) : E298 - E303
  • [28] Relationship between treatment and cost with visual acuity improvement in age-related macular degeneration
    Casanovas-Marsal, Josep-Oriol
    Palomar, Elisa Vilades
    Bartol-Puyal, Francisco de Asis
    Vian, Ruben Hernandez
    Julvez, Luis E. Pablo
    ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2023, 46 (03)
  • [29] Mental health and visual acuity in patients with age-related macular degeneration
    Cheryl N. Fonteh
    Marc T. Mathias
    Naresh Mandava
    Niranjan Manoharan
    Anne M. Lynch
    Roxanne Navo
    Jennifer L. Patnaik
    BMC Ophthalmology, 22
  • [30] Comparison of visual acuity outcomes between ranibizumab and bevacizumab treatment in neovascular age-related macular degeneration
    Feng, Xue-Feng
    Constable, Ian J.
    McAllister, Ian L.
    Isaacs, Timothy
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2011, 4 (01) : 85 - 88